Welcome to the Trecondi® website
Important notice: this site is intended for UK healthcare professionals only. By entering this site, you are confirming that you are a UK healthcare professional. This site may contain promotional information.
I am a UK healthcare professional.
I am a member of the general public.
If you are not a UK healthcare professional but would like further information, please visit medac Pharma or refer to the Trecondi® Summary of Product Characteristics (UK).
Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk.
Adverse events should also be reported to medac drug safety at: drugsafety@medac.de
Most common adverse events in adult patients (all grades): Infections, sepsis, Myelosuppression, pancytopenia, febrile, Neutropeniam, Hypersensitivity, Decreased appetite, Insomnia, Headache, dizziness, Cardiac arrhythmias (e.g. atrial fibrillation, sinus arrhythmia), Hypertension, hypotension, flushing, Dyspnoea, epistaxis, Stomatitis/mucositis, diarrhoea, nausea, vomiting, Oral pain, gastritis, dyspepsia, constipation, dysphagia, abdominal pain, oesophageal or gastrointestinal pain, Maculo-papular rash, purpura, erythema, palmar-plantar erythrodysaesthesia syndrome, pruritus, alopecia, Pain in extremity, back pain, bone pain, Arthralgia, Acute kidney injury, haematuria, Asthenic conditions (fatigue, asthenia, lethargy), Oedema, pyrexiae, chills, Blood bilirubin increased, Transaminases (ALT/AST) increased, γ GT. increased, C-reactive protein increased, weight decreased, weight increased.